# ENDRA Life Sciences Inc.: Form 8-K, filed Oct 30, 2025

- Company: [ENDRA Life Sciences Inc.](/companies/ndra.md) (CIK 1681682)
- Form: 8-K
- Filed: 2025-10-30
- Accepted by EDGAR: Oct 29, 2025, 21:15 ET
- Period: 2025-10-29
- Accession: 0001213900-25-103707
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1681682/000121390025103707/ea0263059-8k_endra.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1681682/000121390025103707/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1681682/000121390025103707/ea0263059-8k_endra.htm

Filed Oct 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-103707. Last ingested by Listed: Nov 6, 2026, 16:42 ET. No prices; not investment advice.